• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重症社区获得性肺炎:影响重症监护治疗需求及预后的因素

Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis.

作者信息

Ortqvist A, Sterner G, Nilsson J A

出版信息

Scand J Infect Dis. 1985;17(4):377-86. doi: 10.3109/13813458509058778.

DOI:10.3109/13813458509058778
PMID:4089544
Abstract

53 patients with community-acquired pneumonia requiring treatment in an Intensive Care Unit (ICU) were studied retrospectively. The majority of patients (77%) had some predisposing factor: illness, smoking or alcoholism. A cause of pneumonia was established in 53% of the cases; Streptococcus pneumoniae was the dominating pathogen. Immediate active treatment was required in 70% of the patients and 58% were treated with mechanical ventilation. The overall mortality was 25% (32% among patients treated with mechanical ventilation) and rose to 39% when a follow-up period of 3.25 years on average was included. A significantly higher mortality rate was seen among elderly patients and among those who were previously immunocompromised or who had a leukocyte count of less than or equal to 9 X 10(9)/l on admission to hospital. It is concluded that although the mortality rate was considerable among the 53 ICU-treated patients with severe community-acquired pneumonias, several were saved by intensive care treatment. Most of those who survived their pneumonia eventually recovered fully.

摘要

对53例需要在重症监护病房(ICU)接受治疗的社区获得性肺炎患者进行了回顾性研究。大多数患者(77%)有一些易感因素:疾病、吸烟或酗酒。53%的病例确定了肺炎病因;肺炎链球菌是主要病原体。70%的患者需要立即进行积极治疗,58%的患者接受了机械通气治疗。总体死亡率为25%(接受机械通气治疗的患者中为32%),当平均纳入3.25年的随访期时,死亡率升至39%。老年患者以及入院时曾免疫功能低下或白细胞计数小于或等于9×10⁹/L的患者死亡率明显更高。结论是,尽管在这53例接受ICU治疗的重症社区获得性肺炎患者中死亡率相当高,但重症监护治疗挽救了一些患者的生命。大多数肺炎幸存者最终完全康复。

相似文献

1
Severe community-acquired pneumonia: factors influencing need of intensive care treatment and prognosis.重症社区获得性肺炎:影响重症监护治疗需求及预后的因素
Scand J Infect Dis. 1985;17(4):377-86. doi: 10.3109/13813458509058778.
2
Prognosis in community-acquired pneumonia requiring treatment in hospital. Importance of predisposing and complicating factors, and of diagnostic procedures.需要住院治疗的社区获得性肺炎的预后。诱发因素和并发症因素以及诊断程序的重要性。
Scand J Infect Dis Suppl. 1990;65:1-62.
3
Community- and hospital-acquired pneumonia in medical intensive care unit.医学重症监护病房中的社区获得性肺炎和医院获得性肺炎
J Med Assoc Thai. 1993 Mar;76(3):129-37.
4
Community-acquired pneumonia in patients with chronic obstructive pulmonary disease requiring admission to the intensive care unit: risk factors for mortality.慢性阻塞性肺疾病患者因社区获得性肺炎入住重症监护病房:死亡的危险因素。
J Crit Care. 2013 Dec;28(6):975-9. doi: 10.1016/j.jcrc.2013.08.004. Epub 2013 Sep 24.
5
Severe community-acquired pneumonia in the elderly: epidemiology and prognosis. Study Group for Severe Community-Acquired Pneumonia.老年人重症社区获得性肺炎:流行病学与预后。重症社区获得性肺炎研究组。
Clin Infect Dis. 1996 Oct;23(4):723-8. doi: 10.1093/clinids/23.4.723.
6
Nosocomial pneumonia in medical intensive care unit.医学重症监护病房中的医院获得性肺炎。
J Assoc Physicians India. 2000 Nov;48(11):1070-3.
7
Re-evaluation of pneumonia requiring admission to an intensive care unit: a prospective study.对需要入住重症监护病房的肺炎的重新评估:一项前瞻性研究。
Thorax. 1994 Jan;49(1):71-6. doi: 10.1136/thx.49.1.71.
8
Severe community acquired pneumonia: a one-year analysis in a tertiary referral intensive care unit.重症社区获得性肺炎:在一家三级转诊重症监护病房的一年分析
N Z Med J. 2000 May 12;113(1109):161-4.
9
Severe varicella-zoster virus pneumonia: a multicenter cohort study.严重水痘-带状疱疹病毒肺炎:一项多中心队列研究。
Crit Care. 2017 Jun 7;21(1):137. doi: 10.1186/s13054-017-1731-0.
10
Prognostic factors of pneumonia requiring admission to the intensive care unit.需要入住重症监护病房的肺炎的预后因素。
Chest. 1995 Feb;107(2):511-6. doi: 10.1378/chest.107.2.511.

引用本文的文献

1
[Guidelines for the management of community pneumonia in adult who needs hospitalization].[成人社区获得性肺炎住院治疗管理指南]
Med Intensiva. 2005 Feb;29(1):21-62. doi: 10.1016/S0210-5691(05)74199-1. Epub 2009 Jan 6.
2
Predicting 30-day mortality of patients with pneumonia in an emergency department setting using machine-learning models.使用机器学习模型预测急诊科环境下肺炎患者的30天死亡率。
Clin Exp Emerg Med. 2020 Sep;7(3):197-205. doi: 10.15441/ceem.19.052. Epub 2020 Sep 30.
3
Clinical Aspects of Upper and Lower Respiratory Tract Infections.
上、下呼吸道感染的临床方面
Drug Investig. 1993;6(Suppl 1):1-14. doi: 10.1007/BF03258432. Epub 2012 Oct 26.
4
Severe pneumonia in the elderly: a multivariate analysis of risk factors.老年人重症肺炎:危险因素的多变量分析
Int J Clin Exp Med. 2015 Aug 15;8(8):12463-75. eCollection 2015.
5
Patients with community acquired pneumonia admitted to European intensive care units: an epidemiological survey of the GenOSept cohort.入住欧洲重症监护病房的社区获得性肺炎患者:GenOSept队列的流行病学调查
Crit Care. 2014 Apr 1;18(2):R58. doi: 10.1186/cc13812.
6
Community acquired, nursing home acquired and hospital acquired pneumonia: A five-year review of the clinical, bacteriological and radiological characteristics.社区获得性、养老院获得性和医院获得性肺炎:临床、细菌学和放射学特征的五年回顾
Can J Infect Dis. 1995 Nov;6(6):317-24. doi: 10.1155/1995/405304.
7
Guidelines for the management of adult lower respiratory tract infections--full version.成人下呼吸道感染管理指南——全文版。
Clin Microbiol Infect. 2011 Nov;17 Suppl 6(Suppl 6):E1-59. doi: 10.1111/j.1469-0691.2011.03672.x.
8
The utility of blood culture in patients with community-acquired pneumonia.血培养在社区获得性肺炎患者中的应用
Ochsner J. 2001 Apr;3(2):85-93.
9
Summary of Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society.加拿大社区获得性肺炎初始管理指南摘要:加拿大传染病协会和加拿大胸科学会基于证据的更新
Can J Infect Dis. 2000 Sep;11(5):237-48. doi: 10.1155/2000/457147.
10
BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.英国胸科学会成人社区获得性肺炎管理指南
Thorax. 2001 Dec;56 Suppl 4(Suppl 4):IV1-64. doi: 10.1136/thorax.56.suppl_4.iv1.